Executive record
Alpha ID: alpha:person:james-hippelVersion: public-0As of: 2026-09-28
Key Claims
Biography
CFO since 2014, Hippel previously served as CFO for Mirion Technologies and held financial roles at Thermo Fisher Scientific and Honeywell.
Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.
Executive career
- 2025 to end not publishedExecutive title: Executive Vice President and Chief Financial Officer · Organization not publishedTECH 10-K executive officers
Claims
Conflicts and accountability
Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.
Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.
Evidence, history and coverage
Additional published Claims
Published evidence records
2 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
TECH 10-K executive officers
sec filing · Source published: Aug 22, 2025 · Retrieved: Apr 29, 2026
Supports 6 claims
- AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: Apr 29, 2026
- Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: Apr 29, 2026
- Executive company: Executive at Bio-Techne Corporation · Claim reviewed: May 3, 2026
- Executive title: Executive title: Executive Vice President and Chief Financial Officer · Claim reviewed: May 3, 2026
- Other Company Role: James Hippel is also linked to Mirion Technologies, Inc as Senior Vice President and Chief Financial Officer. · Claim reviewed: Apr 29, 2026
- Technology background: Technology background reported in filings · Claim reviewed: Apr 29, 2026
TECH executive roster source
sec filing · Source published: Date unavailable · Retrieved: May 3, 2026
Supports 5 claims
- AI expertise: AI expertise reported in filings · Claim reviewed: May 3, 2026
- AI governance relevance: AI governance relevance reported from role and filings · Claim reviewed: May 3, 2026
- Executive company: Executive at Bio-Techne Corporation · Claim reviewed: May 3, 2026
- Executive function: Finance Controls (CFO) · Claim reviewed: May 3, 2026
- Executive title: Executive title: Executive Vice President and Chief Financial Officer · Claim reviewed: May 3, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
corroborated
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-09-28
- Biography
- published
- Board service
- not observed
- Executive career
- published
- Education and qualifications
- not observed
- Compensation
- not observed
- Conflicts and accountability
- not observed
- Background screening
- out of scope

